Central Nervous System Cancer-Refresher 2017 is organized by American Society for Radiation Oncology (ASTRO) and will be held from Sep 14, 2017 - Sep 13, 2020.
The target audience for this medical event is radiation oncologists and radiation oncology residents. This CME Conference has been approved for a maximum of 1.50 AMA PRA Category 1 Credits.
This review session will cover the data upon which the current clinical management is based for both benign and malignant adult CNS tumors. Data-based recommendations from randomized trials will be emphasized as well as clinically relevant practice patterns. The neurocognitive side effects of our treatments will be reviewed. Areas of controversy and future research will be highlighted.
Upon completion of this activity, participants should be able to:
• Describe the current clinical data underlying the treatment of benign and malignant adult CNS tumors.
• Review the data-based recommendations for chemotherapy, surgery and radiotherapy for these tumors.
• Identify the evolving molecular tests in CNS tumors which will guide treatment recommendations.
• Discuss the benefits and side effects of the multiple treatment options for brain metastases.
Additional details will be posted as soon as they are available.
Radiation Oncology, Neuroscience